Partner projects within the Strategy AV21 of the Czech Academy of Sciences
In January 2022, a new research programme “Towards precision medicine and gene therapy” coordinated by the Institute of Molecular Genetics of the Czech Academy of Sciences was approved by the Science Council of the Czech Academy of Sciences.
Objectives:
1) to characterize new pathogenic gene variants that can serve as new gene therapy targets,
2) to provide proof-of-concept of gene therapy for specific diseases in vitro and in vivo models,
3) to develop new tools for gene/drug delivery.
More information in English or in Czech.

